Generic pharmaceutical company NATCO has been granted a compulsory licence to pharmaceutical giant Bayer’s patent for kidney cancer drug Nexavar in India.
If you have already subscribed please login.
If you have any technical issues please email tech support.
NATCO, Bayer, license, Nexavar
Receive daily emails from WIPR